Mesenchymal Stem (Stromal) Cells for Treatment of Acute Respiratory Distress Syndrome

Lancet Respiratory Medicine,The - United Kingdom
doi 10.1016/s2213-2600(15)00047-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Recent Insights: Mesenchymal Stromal/Stem Cell Therapy for Acute Respiratory Distress Syndrome

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2016English

Treatment of Acute Respiratory Distress Syndrome With Allogeneic Adipose-Derived Mesenchymal Stem Cells: A Randomized, Placebo-Controlled Pilot Study

Respiratory Research
PulmonaryRespiratory Medicine
2014English

Surfactant Treatment for Acute Respiratory Distress Syndrome

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1999English

The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment

Annual Review of Pathology: Mechanisms of Disease
MedicineForensic MedicinePathologyPlant Science
2011English

Mesenchymal Stem Cells Reconditioned in Their Own Serum Exhibit Augmented Therapeutic Properties in the Setting of Acute Respiratory Distress Syndrome

Stem cells translational medicine
MedicineDevelopmental BiologyCell Biology
2019English

Emerging Therapies for Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome

Expert Opinion on Emerging Drugs
Pharmacology
2012English

Pathogenesis of Acute Respiratory Distress Syndrome

Seminars in Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2019English

Surfactant Medication for Acute Respiratory Distress Syndrome

Thorax
PulmonaryRespiratory Medicine
1997English

Current Status of Stem Cell Therapy for Sepsis and Acute Respiratory Distress Syndrome

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy